The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Apr 2017 14:03

RNS Number : 0217D
Dechra Pharmaceuticals PLC
21 April 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

DECHRA PHARMACEUTICALS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

FMR LLC

4. Full name of shareholder(s)  (if different from 3.):iv

See Section 9

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

19 April 2017

6. Date on which issuer notified:

21 April 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Indirect

Direct xi

Indirect xii

Direct

Indirect

 

GB0009633180

9,309,883

9,309,883

9,315,883

9,315,883

10.00%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,315,883

10.00%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Controlled Undertaking

Percentage Holding

FIAM LLC

0.11

FIDELITY MANAGEMENT & RESEARCH (JAPAN) LIMITED

0.05

FMR CO., INC

8.82

FMR INVESTMENT MANAGEMENT (UK) LIMITED

1.02

Grand Total

10.00

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will acquire/ cease to hold:

12. Date on which proxy holder will acquire/ cease to hold voting rights:

13. Additional information:

N/A

14. Contact name:

Sally-Ann Hatton

15. Contact telephone number:

 

fil-regreporting@fil.com, 01737 837148

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGMGZDFMMGNZM
Date   Source Headline
11th Dec 20239:45 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
11th Dec 20238:54 amRNSForm 8.3 - Dechra Pharmaceuticals plc
8th Dec 20233:30 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
8th Dec 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
8th Dec 20233:25 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
8th Dec 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
8th Dec 20232:49 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
8th Dec 20232:29 pmRNSHolding(s) in Company
8th Dec 20231:43 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
8th Dec 20231:37 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
8th Dec 20231:17 pmPRNForm 8.3 - Dechra Pharmaceuticals Plc
8th Dec 202312:46 pmRNSForm 8.3 - Dechra Pharmaceuticals PLC
8th Dec 202312:02 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
8th Dec 202311:27 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
8th Dec 202311:25 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
8th Dec 202311:02 amRNSForm 8.3 - Dechra Pharmaceuticals Plc
8th Dec 202310:44 amRNSForm 8.5 (EPT/RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20239:53 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals Plc
8th Dec 20239:02 amRNSForm 8.3 - Dechra Pharmaceuticals plc
7th Dec 20236:24 pmRNSRule 2.9 Announcement
7th Dec 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
7th Dec 20233:25 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
7th Dec 20233:16 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
7th Dec 20232:21 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
7th Dec 20232:17 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
7th Dec 20231:56 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
7th Dec 20231:56 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
7th Dec 20231:37 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
7th Dec 20231:04 pmPRNForm 8.3 - Dechra Pharmaceuticals plc
7th Dec 202311:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
7th Dec 202311:19 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
7th Dec 202311:05 amRNSForm 8.5 (EPT/RI)
7th Dec 202311:01 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Amend
7th Dec 202311:01 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Amend
7th Dec 202310:53 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 202310:25 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
7th Dec 20238:44 amRNSForm 8.3 - Dechra Pharmaceuticals plc
6th Dec 20233:25 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
6th Dec 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
6th Dec 20233:17 pmRNSForm 8.5 (EPT/RI)- Replacement of Dechra
6th Dec 20233:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
6th Dec 20231:51 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
6th Dec 20231:22 pmPRNForm 8.3 - Dechra Pharmaceuticals Plc
6th Dec 202312:07 pmRNSHolding(s) in Company
6th Dec 202311:43 amRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
6th Dec 202311:41 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
6th Dec 202311:34 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
6th Dec 202311:24 amRNSForm 8.3 - Dechra Pharmaceuticals plc
6th Dec 202310:24 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.